Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. SCHEDULE 13D/A Stake Beneficial Ownership Report
  7. 4 Open-market buy Director bought 2,777,777 shares at $9.00 ($24,999,993)
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 8-K Event Material agreement · Results of operations
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. 8-K Event Other events
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 31 · 616 filings